Virpax Pharmaceuticals, Inc. (CIK: 0001708331) EDGAR, Information, Filings... CompaniesBIO.Com

Virpax Pharmaceuticals, Inc.

Mailing address
1554 PAOLI PIKE #279, WEST CHESTER, Delaware, 19380
Phone
484-875-3195
State location
Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Virpax Pharmaceuticals, Inc. (CIK: 0001708331) is an American company incorporated in the state of Pennsylvania. Head office is located at 1554 PAOLI PIKE #279, WEST CHESTER, Pennsylvania, 19380. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Virpax Pharmaceuticals, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Mathias Sheila	0001991182	Sep-27-2023	officer: Chief Scientific Officer
Shah Vinay	0001753078	Jun-20-2023	officer: Chief Financial Officer
Ruskin Barbara	0001969041	Mar-24-2023	director
Dubin Michael F	0001876497	Jul-26-2021	director
JACOB GARY S	0001266802	Apr-07-2021	director
Chipman Christopher Michael	0001354941	Apr-07-2021	officer: Chief Financial Officer
Singh Vanila	0001795397	Apr-07-2021	director
Gudin Jeffrey	0001818449	Apr-07-2021	director, officer: Chief Medical Officer
Jambulingam Thani	0001818466	Apr-07-2021	director
Floyd Eric	0001818469	Apr-07-2021	director
Sendrow Jerrold	0001818472	Apr-07-2021	director
Mack Anthony P.	0001818483	Apr-07-2021	director, 10 percent owner, officer: Chief Executive Officer
Bruce Gerald W	0001361013	Feb-16-2021	officer: EVP, Commercial Operations
Virpax Pharmaceuticals LLC	0001842247	Feb-16-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Virpax Pharmaceuticals, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001731122-24-001482 (34 Act) Size: KB	Sep-25-2024	001-40064 241324200
8-K	Document	Current report filing Acc-no: 0001731122-24-001427 (34 Act) Size: KB	Sep-17-2024	001-40064 241304374
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001213900-24-067945 (33 Act) Size: KB	Aug-13-2024	333-281080 241199038
8-K	Document	Current report filing Acc-no: 0001213900-24-067908 (34 Act) Size: KB	Aug-13-2024	001-40064 241198791
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-067700 (34 Act) Size: KB	Aug-12-2024	001-40064 241197146
8-K	Document	Current report filing Acc-no: 0001013762-24-002775 (34 Act) Size: KB	Jul-30-2024	001-40064 241158990
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001013762-24-002110 (33 Act) Size: KB	Jul-29-2024	333-281080 241152845
8-K	Document	Current report filing Acc-no: 0001013762-24-001638 (34 Act) Size: KB	Jul-26-2024	001-40064 241147519
8-K	Document	Current report filing Acc-no: 0001213900-24-063753 (34 Act) Size: KB	Jul-24-2024	001-40064 241136129
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-061450 ( Act) Size: 0 KB	Jul-15-2024
8-K	Document	Current report filing Acc-no: 0001213900-24-061170 (34 Act) Size: KB	Jul-15-2024	001-40064 241115888
D	Document	Acc-no: 0001213900-24-061018 (33 Act) Size: KB	Jul-12-2024	021-518634 241114452
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-060500 ( Act) Size: 0 KB	Jul-10-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-060496 ( Act) Size: 0 KB	Jul-10-2024
8-K	Document	Current report filing Acc-no: 0001213900-24-060385 (34 Act) Size: KB	Jul-10-2024	001-40064 241109392
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-060120 ( Act) Size: 0 KB	Jul-09-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-060119 ( Act) Size: 0 KB	Jul-09-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-060118 ( Act) Size: 0 KB	Jul-09-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-060117 ( Act) Size: 0 KB	Jul-09-2024
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001213900-24-059838 (34 Act) Size: KB	Jul-08-2024	001-40064 241105261

Recent 20 filings. View all Virpax Pharmaceuticals, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Virpax Pharmaceuticals, Inc. overview
Virpax Pharmaceuticals, Inc. job
Virpax Pharmaceuticals, Inc. stock
Virpax Pharmaceuticals, Inc. ownership
Virpax Pharmaceuticals, Inc. CEO
Virpax Pharmaceuticals, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.